Prevalence of and risk factors for biliary carriage of bacteria showing worrisome and unexpected resistance traits

Journal of Clinical Microbiology

Volumn 51, Issue 2, 2013, Pages 518-521

  Maseda, E ^a   Maggi, G ^a   Gomez Gil, R ^b   Ruiz, G ^b   Madero, R ^a   Garcia Perea, A ^b   Aguilar, L ^c   Gilsanz, F ^a   Rodriguez Bano J ^d  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c SCHOOL OF MEDICINE   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; IMIPENEM; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; BILIARY TRACT INFECTION; BIOLOGICAL TRAIT; CONTROLLED STUDY; DRUG EXPOSURE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENTEROBACTER CLOACAE; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RISK FACTOR; UNEXPECTED RESISTANCE TRAIT;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BILE; BILE DUCT DISEASES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84873044183     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02469-12     Document Type: Article

References (29)

1. Csendes A, Burdiles P, Maluenda F, Diaz JC, Csendes P, Mitru N. 1996. Simultaneous bacteriologic assessment of bile from gallbladder and common bile duct in control subjects and patients with gallstones and common duct stones. Arch. Surg. 131:389 -394.
2. Csendes A, Mitru N, Maluenda F, Diaz JC, Burdiles P, Csendes P, Pinones E. 1996. Counts of bacteria and pyocites of choledochal bile in controls and in patients with gallstones or common bile duct stones with or without acute cholangitis. Hepatogastroenterology 43:800-806.
3. Johannsen EC, Madoff LC. 2005. Infections of the liver and biliary system, p 951-959. In Mandell GL, Bennett JE, Dolin R (ed), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 6th ed. Elsevier Inc., Philadelphia, PA.
4. Brody LA, Brown KT, Getrajdman GI, Kannegieter LS, Brown AE, Fong Y, Blumgart LH. 1998. Clinical factors associated with positive bile cultures during primary percutaneous biliary drainage. J. Vasc. Interv. Radiol. 9:572-578.
5. Calpena Rico R, Sánchez Llinares JR, Candela Polo F, Pérez Vázquez MT, Vázquez Rojas JL, Diego Estévez M, Compañ Rosique A, Medrano Heredia J. 1989. Bacteriologic findings as a prognostic factor in the course of acute cholecystitis. Rev. Esp. Enferm. Apar. Dig. 76:465- 470.
6. Abeysuriya V, Deen KI, Wijesuriya T, Salgado SS. 2008. Microbiology of gallbladder bile in uncomplicated symptomatic cholelithiasis. Hepatobiliary Pancreat. Dis. Int. 7:633- 637.
7. Mahafzah AM, Daradkeh SS. 2009. Profile and predictors of bile infection in patients undergoing laparoscopic cholecystectomy. Saudi Med. J. 30:1044 -1048.
8. Nord CE. 1990. Incidence and significance of intraperitoneal aerobic and anaerobic bacteria. Clin. Ther. 12(Suppl B):9 -20.
9. Ohdan H, Oshiro H, Yamamoto Y, Tanaka I, Inagaki K, Sumimoto K, Hinoi T. 1993. Bacteriological investigation of bile in patients with cholelithiasis. Surg. Today 23:390 -395.
10. den Hoed PT, Boelhouwer RU, Veen HF, Hop WC, Bruining HA. 1998. Infections and bacteriological data after laparoscopic and open gallbladder surgery. J. Hosp. Infect. 39:27-37.
11. Gold-Deutch R, Mashiach R, Boldur I, Ferszt M, Negri M, Halperin Z, Lin G, Sackier J, Halevy A. 1996. How does infected bile affect the postoperative course of patients undergoing laparoscopic cholecystectomy? Am. J. Surg. 172:272-274.
12. Hirschmann JV. 1999. Pyogenic biliary tract and hepatic infections, p 597-603. In Root RK, Waldvogel F, Corey L, Stamm WE (ed), Clinical infectious diseases. A practical approach. Oxford University Press, Inc., Oxford, United Kingdom.
13. Morris-Stiff GJ, O'Donohue P, Ogunbiyi S, Sheridan WG. 2007. Microbiological assessment of bile during cholecystectomy: is all bile infected? HPB (Oxford) 9:225-228.
14. Sanabria A, Dominguez LC, Valdivieso E, Gomez G. 2010. Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomy. Cochrane Database Syst. Rev. 12:CD005265. doi:10.1002/14651858 .CD005265.pub2.
15. Dunne WM Jr, Hardin DJ. 2005. Use of several inducer and substrate antibiotic combinations in a disk approximation assay format to screen for AmpC induction in patient isolates of Pseudomonas aeruginosa, Enterobacter spp., Citrobacter spp., and Serratia spp. J. Clin. Microbiol. 43:5945-5949.
16. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. 2006. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368:874-885.
17. Leclercq R. 2009. Epidemiological and resistance issues in multidrugresistant staphylococci and enterococci. Clin. Microbiol. Infect. 15:224- 231.
18. Queenan AM, Bush K. 2007. Carbapenemases: the versatile betalactamases. Clin. Microbiol. Rev. 20:440-458.
19. Rodríguez-Baño J, Navarro MD, Romero L, Martínez- Martínez L, Muniain MA, Perea EJ, Pérez-Cano R, Pascual A. 2004. Epidemiology and clinical features of infections caused by extended-spectrum betalactamase- producing Escherichia coli in nonhospitalized patients. J. Clin. Microbiol. 42:1089 -1094.
20. Maseda E, Maggi G, Gomez-Gil R, Ruiz G, Madero R, Garcia-Perea A, Aguilar L, Gilsanz F, Rodriguez-Baño J. 2012. Abstr. 52nd Intersci. Conf. Antimicrob. Agents Chemother., abstr. K-1608.
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40:373-383.
22. Fernandez R, Baigorri F, Navarro G, Artigas A. 2006. A modified McCabe score for stratification of patients after intensive care unit discharge: the Sabadell score. Crit. Care 10:R179.
23. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement M100-S21. CLSI, Wayne, PA.
24. Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A, Norwegian ESBL Study Group. 2007. Effects of phenotype and genotype on methods for detection of extended-spectrum-β-lactamase- producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J. Clin. Microbiol. 45:199 -205.
25. Samy AK, MacBain G. 1995. Association of positive bile cultures with the magnitude of surgery and the patients' age. J. R. Coll. Surg. Edinb. 40:188- 191.
26. Landau O, Kott I, Deutsch AA, Stelman E, Reiss R. 1992. Multifactorial analysis of septic bile and septic complications in biliary surgery. World J. Surg. 16:962-964.
27. Augustin P, Kermarrec N, Muller-Serieys C, Lasocki S, Chosidow D, Marmuse JP, Valin N, Desmonts JM, Montravers P. 2010. Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis. Crit. Care 14:R20.
28. Seguin P, Fédun Y, Laviolle B, Nesseler N, Donnio PY, Mallédant Y. 2010. Risk factors for multidrug-resistant bacteria in patients with postoperative peritonitis requiring intensive care. J. Antimicrob. Chemother. 65:342-346.
29. Paterson DL, Bonomo RA. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657- 686.